T 27 Pill - white oval
Pill with imprint T 27 is White, Oval and has been identified as Carbamazepine (Chewable) 200 mg. It is supplied by Taro Pharmaceutical Industries Ltd.
Carbamazepine is used in the treatment of Trigeminal Neuralgia; Bipolar Disorder; Schizoaffective Disorder; Epilepsy; Seizures and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for T 27
Carbamazepine (Chewable)
- Imprint
- T 27
- Strength
- 200 mg
- Color
- White
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Taro Pharmaceutical Industries Ltd.
- National Drug Code (NDC)
- 51672-4050
- Inactive Ingredients
-
croscarmellose sodium,
diethyl phthalate,
FD&C Red No. 40,
aluminum oxide,
magnesium stearate,
microcrystalline cellulose,
corn starch,
sorbitol
Note: Inactive ingredients may vary.
Related images for "T 27"
More about carbamazepine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (345)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Carbamazepine drug information
- Carbamazepine (Intravenous) (Advanced Reading)
- Carbamazepine Chewable Tablets
- Carbamazepine Extended-Release Tablets
- Carbamazepine Extended-Release Capsules (Carbatrol)
Other brands
Tegretol, Tegretol XR, Carbatrol, Epitol, ... +2 more
Professional resources
- Carbamazepine monograph
- Carbamazepine (FDA)
- Carbamazepine Capsules (FDA)
- Carbamazepine Chewable (FDA)
- Carbamazepine ER (FDA)
- Carbamazepine Oral Suspension (FDA)
Other brands
Tegretol, Carbatrol, Epitol, Equetro, Carnexiv
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
